1
|
Buis DTP, Prins JM, Betica-Radic L, de Boer MGJ, Ekkelenkamp M, Kofteridis D, Peiffer-Smadja N, Schouten J, Spernovasilis N, Tattevin P, ten Oever J, Sigaloff KCE. Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia: results from a survey in five European countries. J Antimicrob Chemother 2022; 77:2827-2834. [PMID: 35869753 PMCID: PMC9797040 DOI: 10.1093/jac/dkac237] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Accepted: 06/17/2022] [Indexed: 01/01/2023] Open
Abstract
OBJECTIVES To determine clinical practice variation and identify knowledge gaps in antibiotic treatment of Staphylococcus aureus bacteraemia (SAB). METHODS A web-based survey with questions addressing antibiotic treatment of SAB was distributed through the ESGAP network among infectious disease specialists, clinical microbiologists and internists in Croatia, France, Greece, the Netherlands and the UK between July 2021 and November 2021. RESULTS A total number of 1687 respondents opened the survey link, of whom 677 (40%) answered at least one question. For MSSA and MRSA bacteraemia, 98% and 94% preferred initial monotherapy, respectively. In patients with SAB and non-removable infected prosthetic material, between 80% and 90% would use rifampicin as part of the treatment. For bone and joint infections, 65%-77% of respondents would consider oral step-down therapy, but for endovascular infections only 12%-32% would. Respondents recommended widely varying treatment durations for SAB with different foci of infection. Overall, 48% stated they used 18F-fluorodeoxyglucose positron emission tomography/CT (18F-FDG-PET/CT) to guide antibiotic treatment duration. Persistent bacteraemia was the only risk factor for complicated SAB that would prompt a majority to extend treatment from 2 to 4-6 weeks. CONCLUSIONS This survey in five European countries shows considerable clinical practice variation between and within countries in the antibiotic management of SAB, in particular regarding oral step-down therapy, choice of oral antibiotic agents, treatment duration and use of 18F-FDG-PET/CT. Physicians use varying criteria for treatment decisions, as evidence from clinical trials is often lacking. These areas of practice variation could be used to prioritize future studies for further improvement of SAB care.
Collapse
Affiliation(s)
| | - J M Prins
- Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, De Boelelaan 1117, Amsterdam, The Netherlands
| | - L Betica-Radic
- General Hospital Dubrovnik, Department of Infectious Diseases, University of Dubrovnik, Dubrovnik, Croatia
| | - M G J de Boer
- Leiden University Medical Center, Department of Infectious Diseases, Leiden, The Netherlands
| | - M Ekkelenkamp
- UMC Utrecht, Department of Medical Microbiology, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
| | - D Kofteridis
- Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, Greece
| | - N Peiffer-Smadja
- Infectious Disease Department, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France
| | - J Schouten
- Department of Intensive Care Medicine, Radboudumc, Nijmegen, The Netherlands
| | - N Spernovasilis
- Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, Greece,Department of Infectious Diseases, German Oncology Center, Limassol, Cyprus
| | - P Tattevin
- Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France
| | - J ten Oever
- Radboud University Medical Center, Department of Internal Medicine and Radboud Center for Infectious Diseases, Geert Grooteplein Zuid 10, Nijmegen, The Netherlands
| | - K C E Sigaloff
- Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, De Boelelaan 1117, Amsterdam, The Netherlands
| |
Collapse
|
2
|
Vilibic-Cavlek T, Stevanovic V, Tabain I, Betica-Radic L, Sabadi D, Peric L, Bogdanic M, Vilibic M, Kolaric B, Kudumija B, Petrovic G, Mrzljak A, Karabuva S, Hrstic I, Capak K, Kucinar J, Savic V, Barbic L. Severe acute respiratory syndrome coronavirus 2 seroprevalence among personnel in the healthcare facilities of Croatia, 2020. Rev Soc Bras Med Trop 2020; 53:e20200458. [PMID: 32876319 PMCID: PMC7451497 DOI: 10.1590/0037-8682-0458-2020] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Accepted: 07/21/2020] [Indexed: 02/07/2023] Open
Affiliation(s)
- Tatjana Vilibic-Cavlek
- Croatian Institute of Public Health, Department of Virology, Zagreb,
Croatia
- University of Zagreb, School of Medicine, Zagreb, Croatia
| | - Vladimir Stevanovic
- University of Zagreb, Faculty of Veterinary Medicine, Department of
Microbiology and Infectious Diseases with Clinic, Zagreb, Croatia
| | - Irena Tabain
- Croatian Institute of Public Health, Department of Virology, Zagreb,
Croatia
| | | | - Dario Sabadi
- Clinical Hospital Center Osijek, Department of Infectious Diseases,
Osijek, Croatia
- Josip Juraj Strossmayer University of Osijek, Medical Faculty,
Osijek, Croatia
| | - Ljiljana Peric
- Clinical Hospital Center Osijek, Department of Infectious Diseases,
Osijek, Croatia
- Josip Juraj Strossmayer University of Osijek, Medical Faculty,
Osijek, Croatia
| | - Maja Bogdanic
- Croatian Institute of Public Health, Department of Virology, Zagreb,
Croatia
| | - Maja Vilibic
- Sestre Milosrdnice University Hospital Centre, Department of
Psychiatry, Zagreb, Croatia
| | - Branko Kolaric
- Andrija Stampar Teaching Institute of Public Health, Department of
Public Health Gerontology, Zagreb, Croatia
- University of Rijeka, Faculty of Medicine, Rijeka, Croatia
| | - Boris Kudumija
- B. Braun Avitum Polyclinic for Internal Medicine and Dialysis,
Zagreb, Croatia
| | - Goranka Petrovic
- Croatian Institute of Public Health, Department of Epidemiology,
Zagreb, Croatia
| | - Anna Mrzljak
- University of Zagreb, School of Medicine, Zagreb, Croatia
- Merkur University Hospital, Department of Medicine, Zagreb,
Croatia
| | - Svjetlana Karabuva
- University Hospital Center Split, Department of Infectious
Diseases, Split, Croatia
| | - Irena Hrstic
- General Hospital Pula, Department of Medicine, Pula, Croatia
| | - Krunoslav Capak
- Croatian Institute of Public Health, Environmental Health
Department, Zagreb, Croatia
| | - Jasmina Kucinar
- Istria County Institute of Public Health, Department of Serology
and Immunology, Pula, Croatia
| | - Vladimir Savic
- Croatian Veterinary Institute, Laboratory for Virology and
Serology, Zagreb, Croatia
| | - Ljubo Barbic
- University of Zagreb, Faculty of Veterinary Medicine, Department of
Microbiology and Infectious Diseases with Clinic, Zagreb, Croatia
| |
Collapse
|
3
|
Vilibic-Cavlek T, Betica-Radic L, Venturi G, Fortuna C, Djuricic S, Salvia-Milos A, Tabain I, Barbic L, Stevanovic V, Listes E, Savini G. First detection of Zika virus infection in a Croatian traveler returning from Brazil, 2016. J Infect Dev Ctries 2017; 11:662-667. [PMID: 31085829 DOI: 10.3855/jidc.9410] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2016] [Accepted: 10/25/2016] [Indexed: 10/31/2022] Open
Abstract
In the last few years, several imported cases of Zika virus (ZIKV) infection were reported in European countries. We report the first imported ZIKV infection case in a Croatian traveler returning from Brazil. The patient presented with a low-grade fever, pruritic rash, general weakness, myalgia, arthralgia and edema of the legs and recovered completely within a week. ZIKV infection was confirmed by detection of IgM/IgG antibodies using enzyme-linked immunosorbent assay (ELISA) and confirmed by plaque-reduction neutralization test (PRNT). ZIKV IgM antibodies cross-reacted with dengue virus (DENV), West Nile virus (WNV) and tick-borne encephalitis virus (TBEV) in ELISA. In indirect immunofluorescence assay (IFA), IgM cross-reactivity was found only with DENV-3. ZIKV IgG antibodies cross-reacted with DENV in both ELISA and IFA. PRNT for DENV was negative. Control serology performed on days 64 and 98 after disease onset showed a decline in cross-reactive heterologous DENV IgG antibodies compared to persistently high titer of homologous ZIKV IgG antibodies.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Irena Tabain
- Croatian National Institute of Public Health, Zagreb, Croatia.
| | - Ljubo Barbic
- Faculty of Veterinary Medicine, University of Zagreb, Zagreb, Croatia.
| | | | - Eddy Listes
- Croatian Veterinary Institute, Regional Institute Split, Split, Croatia.
| | - Giovanni Savini
- Istituto Zooprofillatico Sperimentale "G. Caporale", Teramo, Italia.
| |
Collapse
|